TY - JOUR
T1 - Provider communication and HPV vaccination
T2 - The impact of recommendation quality
AU - Gilkey, Melissa B.
AU - Calo, William A.
AU - Moss, Jennifer L.
AU - Shah, Parth D.
AU - Marciniak, Macary W.
AU - Brewer, Noel T.
N1 - Funding Information:
Funding source : This study was funded via an unrestricted educational grant from Merck , Sharp and Dohme (Grant # 8970803 ). Authors’ time was supported by grants from the National Cancer Institute ( K22 CA186979 ; F31 CA189411 ; R25 CA116339 ). Funders played no role in the design and conduct of the study; collection, management, analysis, and interpretation of data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.
PY - 2016/2/24
Y1 - 2016/2/24
N2 - Background: Receiving a healthcare provider's recommendation is a strong predictor of HPV vaccination, but little is known empirically about which types of recommendation are most influential. Thus, we sought to investigate the relationship between recommendation quality and HPV vaccination among U.S. adolescents. Methods: In 2014, we conducted a national, online survey of 1495 parents of 11-17-year-old adolescents. Parents reported whether providers endorsed HPV vaccination strongly, encouraged same-day vaccination, and discussed cancer prevention. Using an index of these quality indicators, we categorized parents as having received no, low-quality, or high-quality recommendations for HPV vaccination. Separate multivariable logistic regression models assessed associations between recommendation quality and HPV vaccine initiation (≥1 dose), follow through (doses, among initiators), refusal, and delay. Results: Almost half (48%) of parents reported no provider recommendation for HPV vaccination, while 16% received low-quality recommendations and 36% received high-quality recommendations. Compared to no recommendation, high-quality recommendations were associated with over nine times the odds of HPV vaccine initiation (23% vs. 74%, OR = 9.31, 95% CI, 7.10-12.22) and over three times the odds of follow through (17% vs. 44%, OR = 3.82, 95% CI, 2.39-6.11). Low-quality recommendations were more modestly associated with initiation (OR = 4.13, 95% CI, 2.99-5.70), but not follow through. Parents who received high- versus low-quality recommendations less often reported HPV vaccine refusal or delay. Conclusions: High-quality recommendations were strongly associated with HPV vaccination behavior, but only about one-third of parents received them. Interventions are needed to improve not only whether, but how providers recommend HPV vaccination for adolescents.
AB - Background: Receiving a healthcare provider's recommendation is a strong predictor of HPV vaccination, but little is known empirically about which types of recommendation are most influential. Thus, we sought to investigate the relationship between recommendation quality and HPV vaccination among U.S. adolescents. Methods: In 2014, we conducted a national, online survey of 1495 parents of 11-17-year-old adolescents. Parents reported whether providers endorsed HPV vaccination strongly, encouraged same-day vaccination, and discussed cancer prevention. Using an index of these quality indicators, we categorized parents as having received no, low-quality, or high-quality recommendations for HPV vaccination. Separate multivariable logistic regression models assessed associations between recommendation quality and HPV vaccine initiation (≥1 dose), follow through (doses, among initiators), refusal, and delay. Results: Almost half (48%) of parents reported no provider recommendation for HPV vaccination, while 16% received low-quality recommendations and 36% received high-quality recommendations. Compared to no recommendation, high-quality recommendations were associated with over nine times the odds of HPV vaccine initiation (23% vs. 74%, OR = 9.31, 95% CI, 7.10-12.22) and over three times the odds of follow through (17% vs. 44%, OR = 3.82, 95% CI, 2.39-6.11). Low-quality recommendations were more modestly associated with initiation (OR = 4.13, 95% CI, 2.99-5.70), but not follow through. Parents who received high- versus low-quality recommendations less often reported HPV vaccine refusal or delay. Conclusions: High-quality recommendations were strongly associated with HPV vaccination behavior, but only about one-third of parents received them. Interventions are needed to improve not only whether, but how providers recommend HPV vaccination for adolescents.
UR - http://www.scopus.com/inward/record.url?scp=84958087379&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84958087379&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2016.01.023
DO - 10.1016/j.vaccine.2016.01.023
M3 - Article
C2 - 26812078
AN - SCOPUS:84958087379
VL - 34
SP - 1187
EP - 1192
JO - Vaccine
JF - Vaccine
SN - 0264-410X
IS - 9
ER -